Cancer Science & Research
Open Access
ISSN: 2639-8478
Research Article
View / Download PDF
Immune-Modulators and Thyroid Function in Oncological Patients with Hashimoto 'S Thyroiditis
Authors: Matozza Francesco, Artero Guillermo H, Artero Guillermo, Levy Daniel, Carvallo Héctor.
Abstract
Hashimoto's thyroiditis (HT) is a form of chronic lymphocytic thyoriditis, of autoimmune origin and multiple physiopathogenic pathways, which may or may not be associated with other autoantibody diseases, both endocrinological (P.A.S.) and non-endocrinological (M.A.S.). Likewise, HT can coincide -in the same patient- with very varied oncological pathologies, with which it can interact in a usually negative way. In this article, the benefit achieved in cancer patients who also had HT is evaluated through the use of immune-modulators.
Citation:
Matozza Francesco, Artero Guillermo H, Artero Guillermo, et al. Immune-Modulators and Thyroid Function in Oncological Patients with Hashimoto 'S Thyroiditis. 2021; 4(2).
DOI:
10.33425/2639-8478.1067
Editor-in-Chief
Lee Guek Eng
Department of Medical Oncology | National University of Singapore
View full editorial board →
Journal Metrics
Impact Factor
2.4*
Acceptance Rate
75%
Time to first decision
6-10 Days
Submission to acceptance
12-15 Days